Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awada

Showing results (11-20 of 1,005) with videos related to

Pageof 101
Sort By:
Discovery Medicine|September 1, 2015
Novel mechanisms and approaches in the medical therapy of solid cancersGil Awada, Hampig R Kourie, Ahmad H Awada
Revue Neurologique|August 12, 2009
[Deep non-reactive reversible coma after a Mediterranean neurotoxic fish poisoning]A Awada, V Chalhoub, L Awada, et al.
Forum (Genoa, Italy)|March 14, 2003
New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancerAhmad Awada
Revue Neurologique|January 1, 1989
[Isolated cheiro-facial formication caused by a thalamic hematoma]A Awada
Revue Neurologique|February 1, 1997
[Blepharospasm caused by bilateral paramedian thalamic infarction]A Awada
Therapeutic Advances in Rare Disease|April 30, 2025
Access to drugs for rare diseases (DRD) in Canada: a comprehensive review of the provincial DRD-specific programsNahya Awada
Current Opinion in Oncology|May 7, 2016
Rare side-effects of checkpoint inhibitorsHampig R Kourie, Gil Awada, Ahmad H Awada
Critical Reviews in Oncology/Hematology|April 7, 2016
Learning from the "tsunami" of immune checkpoint inhibitors in 2015Hampig Raphael Kourie, Gil Awada, Ahmad Hussein Awada
Future Oncology (London, England)|March 23, 2017
Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanomaHampig Raphael Kourie, Hassan Kanaan, Gil Awada, et al.
Current Opinion in Oncology|February 19, 2011
Recurrent thyroid cancer: a molecular-based therapeutic breakthroughYassine Lalami, Ahmad Awada
Pageof 101

Showing results (11-20 of 1,005) with videos related to

Sort By:
Pageof 101
Discovery Medicine|September 1, 2015
Novel mechanisms and approaches in the medical therapy of solid cancersGil Awada, Hampig R Kourie, Ahmad H Awada
Revue Neurologique|August 12, 2009
[Deep non-reactive reversible coma after a Mediterranean neurotoxic fish poisoning]A Awada, V Chalhoub, L Awada, et al.
Forum (Genoa, Italy)|March 14, 2003
New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancerAhmad Awada
Revue Neurologique|January 1, 1989
[Isolated cheiro-facial formication caused by a thalamic hematoma]A Awada
Revue Neurologique|February 1, 1997
[Blepharospasm caused by bilateral paramedian thalamic infarction]A Awada
Therapeutic Advances in Rare Disease|April 30, 2025
Access to drugs for rare diseases (DRD) in Canada: a comprehensive review of the provincial DRD-specific programsNahya Awada
Current Opinion in Oncology|May 7, 2016
Rare side-effects of checkpoint inhibitorsHampig R Kourie, Gil Awada, Ahmad H Awada
Critical Reviews in Oncology/Hematology|April 7, 2016
Learning from the "tsunami" of immune checkpoint inhibitors in 2015Hampig Raphael Kourie, Gil Awada, Ahmad Hussein Awada
Future Oncology (London, England)|March 23, 2017
Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanomaHampig Raphael Kourie, Hassan Kanaan, Gil Awada, et al.
Current Opinion in Oncology|February 19, 2011
Recurrent thyroid cancer: a molecular-based therapeutic breakthroughYassine Lalami, Ahmad Awada
Pageof 101